- Home
- LRE vs AIDX Comparison
LRE vs AIDX Comparison
Compare LRE & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LRE | AIDX |
|---|---|---|
| Founded | 2001 | N/A |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | Precision Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8M | 19.5M |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | LRE | AIDX |
|---|---|---|
| Price | $1.30 | $1.40 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 7.5K | ★ 54.8K |
| Earning Date | 07-30-2015 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $3.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.00 | $1.32 |
| 52 Week High | $2.86 | $14.09 |
Technical Indicators
Market Signals| Indicator | LRE | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 46.47 | 25.83 |
| Support Level | $1.24 | $1.32 |
| Resistance Level | $1.43 | $2.08 |
| Average True Range (ATR) | 0.05 | 0.13 |
| MACD | 0.00 | 0.06 |
| Stochastic Oscillator | 34.62 | 23.08 |
Price Performance
Historical ComparisonAbout LRE Lead Real Estate Co. Ltd
Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.
About AIDX 20/20 Biolabs Inc. Common Stock
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.